首页> 外国专利> Compounds derived from cyclohexylamine, beta2 agonists and antagonists of Muscarinic m3 intermediaries; Compounds; Pharmaceutical composition that comprises; a method for treating Physiological condition or illness; and combination Product comprising the compound and a corticosteroid or an I Nhiidor PDE4.

Compounds derived from cyclohexylamine, beta2 agonists and antagonists of Muscarinic m3 intermediaries; Compounds; Pharmaceutical composition that comprises; a method for treating Physiological condition or illness; and combination Product comprising the compound and a corticosteroid or an I Nhiidor PDE4.

机译:衍生自环己胺,β2激动剂和毒蕈碱m3中间体拮抗剂的化合物;化合物;药物组合物,其包含;治疗生理状况或疾病的方法;以及包含所述化合物和皮质类固醇或Nhiidor PDE4的组合产品。

摘要

The present invention relates to novel compounds having ²2 adrenergic agonist and M3 muscarinic antagonist dual activity, to pharmaceutical compositions containing them, to the process for their preparation and to their use in respiratory therapies.
机译:本发明涉及具有2肾上腺素能激动剂和M3毒蕈碱拮抗剂双重活性的新化合物,含有它们的药物组合物,其制备方法及其在呼吸疗法中的用途。

著录项

  • 公开/公告号CL2014001017A1

    专利类型

  • 公开/公告日2014-06-06

    原文格式PDF

  • 申请/专利权人 ALMIRALL S.A.;

    申请/专利号CL20140001017

  • 申请日2014-04-21

  • 分类号C07D215/26;C07D277/68;C07D403/12;C07D405/12;C07D409/12;C07D409/14;C07D417/14;A61K31/428;A61K31/4709;A61P11/00;

  • 国家 CL

  • 入库时间 2022-08-21 15:58:26

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号